The EMA’s recommendation marks a key step toward expanding treatment access for patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/biosimilar-inflammatory-diseases-clears-eu-hurdle-2025a1000p7a?src=rss
Author :
Publish date : 2025-09-22 15:10:00
Copyright for syndicated content belongs to the linked Source.
